Annual Drug Patent Expirations for XPOVIO
Xpovio is a drug marketed by Karyopharm Theraps and is included in one NDA. There are five patents protecting this drug.
This drug has ninety-one patent family members in thirty-three countries.
The generic ingredient in XPOVIO is selinexor. Additional details are available on the selinexor profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
